Aleksei V. Smirnov

Aleksei V. Smirnov

Auto-generated profile, based on publicly available information

Aleksei V. Smirnov

Pavlov University

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2019 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Open access
PDF file
ASA. V. Smirnov
A. V. Smirnov
BAB. V. Afanasyev
B. V. Afanasyev
IPI. V. Poddubnaya
I. V. Poddubnaya
VDVladimir Dobronravov
Vladimir Dobronravov
MKMaria Khrabrova
Maria Khrabrova
LBL. S. Biryukova
L. S. Biryukova
Monoclonal gammopathy of renal significance (MGRS) is a new nosology in modern nephrology and oncohematology. MGRS is defined as kidney injury due to nephrotoxic monoclonal immunoglobulin produced by the B-cell line clone which does not reach the hematological criteria for specific treatment initiation. Monoclonal protein’s pathological effects on kidney parenchyma result in irreversible decline of kidney function till the end stage renal disease that in line with the position of International Consensus of hematologists and nephrologists determinates critical necessity for clone specific treatment in patients with MGRS despite the absence of hematological indications for treatment initiation. Main challenge of MGRS in Russian Federation is an inaccessibility of an in-time diagnostic and appropriate treatment for the great majority of patients due to the following reasons: i) limited knowledge about the MGRS among hematologists and nephrologists; ii) lack of necessary diagnostic resources in most health-care facilities; iii) lack of approved clinical recommendations and medical economic standards for treatment of this pathological entity. Consensus document comprises the opinion of experts – leading nephrologists and hematologists of Russian Federation – on the problem of MGRS including the incoherence in nosology classification, diagnostics approach and rationale for clone specific treatment. Consensus document is based on conclusions and agreements reached during the conference of leading nephrologists and hematologists of Russia which was held in the framework of symposia «Plasma cell dyscrasias and lymphoproliferative diseases: modern approaches to therapy», 15-16 of March 2019, Pavlov First St-Petersburg State Medical University, St-Petersburg, Russia. The present Consensus is intended to define the principal practical steps to resolve the problem of MGRS in Russian Federation that are summarized as final clauses.

23 June 2019 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Open access
PDF file
ASA. V. Smirnov
A. V. Smirnov
YNYu. V. Natochin
Yu. V. Natochin
Нефрология: фундаментальная и клиническая

1 January 2017 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
IVI. A. Vasilieva
I. A. Vasilieva
AСArray В. Смирнов
Array В. Смирнов
ЦЕЛЬ ИССЛЕДОВАНИЯ. Оценить качество жизни (КЖ) больных, находящихся на лечении гемодиализом (ГД), при помощи опросника Kidney Disease Quality of Life Short Form (KDQOL-SFTM), включающего специфические для диализной терапии разделы. ПАЦИЕНТЫ И МЕТОДЫ. При помощи опросника KDQOL-SF обследовали 192 больных, находившихся на лечении ГД. РЕЗУЛЬТАТЫ. Показано, что больных на ГД отличает низкая удовлетворенность трудоустройством – 0,0 [0,0–50,0] (Me[IQR]) по шкале «трудового статуса». Установлен низкий балл по шкале «бремя заболевания почек» – 31,3 [18,8–50,0]. Наиболее высокие оценки получены по шкалам «когнитивных функций» – 86,9 [66,7–93,3], «качества социального взаимодействия» – 80,0 [66,7–93,3], «социального функционирования» – 62,5 [50,0–87,5], «психического здоровья» – 60,8±18,1 (M±SD). Среди наиболее значимых стресс-факторов – ограниченная возможность путешествовать и ограничения в потреблении жидкости (74% и 66% больных соответственно). Наиболее часты жалобы на мышечные боли (50% больных), повышенную утомляемость (45%), головокружение (44%), зуд (41%), одышку (40%), сухость кожи (34%). ЗАКЛЮЧЕНИЕ. Опросник KDQOL-SF, заполнение которого занимает не более 15–20 минут, дает важную информацию о лимитированных возможностях и наиболее актуальных потребностях диализных пациентов.

1 January 2018 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Open access
PDF file
KVK. A. Vishnevskii
K. A. Vishnevskii
AZAlexander Zemchenkov
Alexander Zemchenkov
RGR. P. Gerasimchuk
R. P. Gerasimchuk
ARAleksandr Rumyantsev
Aleksandr Rumyantsev
ASA. V. Smirnov
A. V. Smirnov
PMP. V. Maryutin
P. V. Maryutin
У большинства пациентов, получающих программный гемодиализ, наблюдаются минерально-костные нарушения, из которых наиболее распространённым является вторичный гиперпаратиреоз. Для коррекции этого жизнеугрожающего осложнения хронической болезни почек в последнее десятилетие разработаны и введены в клиническую практику ряд новых препаратов, таких как парикальцитол, цинакалцет и некоторые фосфат-связывающие медикаменты. Ввиду увеличения государственных затрат на данную терапию во многих странах, в том числе и в России, были проведены ряд фармакоэкономических исследований, призванных определить целесообразность назначения определенных препаратов по критерию «затраты–эффективность». В данном обзоре выполнен краткий анализ методов оценки рентабельности лекарственных препаратов и рассмотрены результаты недавних исследований, посвященных оценке экономической эффективности лечения МКН–ХБП.

1 January 2016 in Russian Journal of Archive of Pathology
Verified
Journal Article
Closed access
VSV. G. Sipovskii
V. G. Sipovskii
IKI. K. Klemina
I. K. Klemina
RZR. V. Zverkov
R. V. Zverkov
VDV. A. Dobronravov
V. A. Dobronravov
ASA. V. Smirnov
A. V. Smirnov
Lipoprotein glomerulopathy (LPG) is a rare disease characterized by specific histological, immunomorphological, and ultrastructural changes. The main pathomorphological signs of LPG are lipoprotein thrombi in the lumen of the capillary loops, proteinuria, and dyslipoproteinemia as an increased concentration of apolipoprotein E (phenotypes E2/E3, E2/E4). A patient aged 47 years had nephrotic syndrome with a daily protein loss of 12.4 g/ day. Light optical microscopic examination of a renal biopsy specimen revealed Sudan III-positive, weakly PAS, and eosin-positive friable thrombi in the lumen of the capillary loops. No deposits of immunoglobulins were immunomorphologically detected in thrombotic masses. The ultrastructure of thrombotic masses was composed of granular masses with numerous vacuoles that formed concentric layers. Thus, LPG was diagnosed as a manifestation of type 3 hyperlipoproteinemia that had characteristic pathological, clinical, and laboratory signs of this disease.

25 December 2019 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
VDVladimir Dobronravov
Vladimir Dobronravov
AKA. V. Karunnaya
A. V. Karunnaya
AKA. V. Kazimirchik
A. V. Kazimirchik
ASA. V. Smirnov
A. V. Smirnov
THE AIM: The analysis of clinical and morphological presentations and outcomes of primary systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA-V) with dominant kidney involvement; the determination of clinical and morphological parameters associated with prognosis.PATIENTS AND METHODS. Eighty nine patients with morphologically confirmed ANCA-associated kidney vasculitis on standard immunosuppressive therapy (IST) were included in this retrospective study. Clinical, immunological, and histological indices were analyzed at the time of the kidney biopsy, and early in the short-term (3-6 months) and in the long-term follow-up. The following outcomes were evaluated: the achievement of clinical and immunological remission of the disease; eGFR at the end of follow-up, the progression of renal disease (by the composite point: initiation of renal replacement therapy (RRT) or the estimated glomerular filtration rate (eGFR) 50 %); all-cause mortality. The prognostic significance of clinical and morphological parameters was evaluated in multivariable regression models.RESULTS. Most of cases (78 %) were represented by rapidly progressive or acute nephritic syndrome. Mean eGFR was 23 ml/min/1.73 m2. Fifteen percent of patients required acute dialysis. Dominant morphological phenotypes of glomerular lesions were sclerotic (34 %) and mixed (36 %) according to the International Pathology Classification (IPC). Median follow-up was 24 (8; 55) months. Cumulative 5-year and 10-year patient’s survivals and were 92 % and 86 %, respectively. Cumulative 5-year and 10-year renal survivals were 86 % and 68 %, respectively. The cumulative 5-year and 10-year proportions of cases without progression of kidney disease were 80 % and 55 %, respectively. Within 3-6 months of the induction IST 81 % of patients achieved clinical remission (complete (59 %) or partial (22 %)) (CR3-6), while 84 % of patients had immunological remission. Serum creatinine (Pcr) at the time of kidney biopsy was only the factor associated with the risk of renal progression (Expβ=1.73 (95 %CI 1.40-2.14) per 0.1 mmol/l increase). IPC classes and ANCA Renal Risk Score (ARRS) groups as well as other morphological indices of kidney injury had no independent associations with the renal outcomes in Cox models adjusted for Pcr. The independent factors associated with eGFR at the end of follow-up were: CR3-6 (β=0.36±0.08, p<0.001); age (β=-0.34±0.09, p<0.001), Pcr (β=-0.35±0.09, p<0.001) and the global glomerulosclerosis (β=0.28±0.08, p<0.001). CR3-6 (β=0.57±0.10, p<0.001), and the proportion of cellular crescents (β=0.26±0.12, p=0.023) and interstitial inflammation (β=0.27±0.11, p=0.026) were also independently associated with the change of eGFR by the end of follow-up.CONCLUSION. An unfavorable renal prognosis for ANCA-V determined by severe renal dysfunction due to inflammatory and fibrotic alterations of the organ can be significantly improved by adequate therapy with the achievement of higher patient’s and kidney’s survival. The baseline serum creatinine is only the factor associated with the long-term risks of dialysis and kidney disease progression. In addition to baseline serum creatinine and the development of early clinical remission, the separate assessment of global glomerular sclerosis, cellular crescents, and interstitial inflammation may be more useful for the individual prediction of long-term eGFR changes than IPC classes or ARRS.